cho_logo_symbol_border

Tag: Vaccines

Many ‘long Covid’ sufferers unable to fully work six months later

Many people suffering from “long Covid” are still unable to work at full capacity six months after infection, a large-scale survey of confirmed and suspected patients has found.

Read More

Study: Evidence based management guideline for the COVID-19 pandemic – Review article

By Maria Nicola, Niamh O’Neill, Catrin Sohrabi, Mehdi Khan, Maliha Agha, and Riaz Agha • Published 2020 Apr 11 Elsevier Public Health Emergency Collection COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 2.5 million people worldwide, resulting in over 170,000 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have

Read More

Higher Reinfection Risk? Vaccine Resistant? NYC Drops New Report on COVID Variants

By Jennifer Millman • Published April 13, 2021 NBC NEW YORK Health officials say they are looking into whether the Washington Heights variant causes a higher risk of reinfection by other variants or is more resistant to vaccines, but they know it’s more contagious More contagious variants are keeping

Read More

Mutations could render current Covid vaccines ineffective in a year or less, epidemiologists warn

By Holly Ellyatt CNBC Published MAR 30 2021 Mutations of the coronavirus could render current vaccines ineffective within a year, according to a survey of experts in 28 countries. Of those surveyed, almost a third gave a time frame of nine months or less. Fewer than 1

Read More

The Pfizer/BioNTech Covid-19 Vaccine Is Less Effective Against The South African And UK Variants Than Against The Original Virus, According To A New “Real-World” Study From Israel

By William A. Haseltine Forbes Published Apr 11, 2021 The novel mRNA vaccines of Moderna and Pfizer/BioNTech are among the most effective of all the developed vaccines at preventing infection and disease. For that, we are all grateful. But even the best vaccines fail to protect some

Read More

In race between vaccines and variants, Massachusetts may be seeing an ‘uncoupling’ of COVID-19 cases and deaths

Experts estimate that the three variants of concern now account for more than half of Massachusetts cases.

Read More

COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough

As COVID-19 cases resulting from infection with SARS-CoV-2 variants accumulate in the US and around the world, one question looms large: How well do the COVID-19 vaccines developed so far protect against these novel coronavirus spinoffs?

Read More

How this more contagious virus variant became dominant in the U.S.

The B.1.1.7 strain is spreading among adults and kids, and experts say that's another reason to get vaccinated, fast.

Read More

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $5,000,000

Funding Goal $5,000,000

20%

Skip to content